Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients with Sitosterolemia

Circulation

Volumn 109, Issue 8, 2004, Pages 966-971

  Salen, Gerald ^a,b,h   Von Bergmann, K ^c   Lutjohann D ^c   Kwiterovich, P ^d   Kane, J ^e   Patel, S B ^f   Musliner, T ^g   Stein, P ^g   Musser, B ^g  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF BONN   (Germany)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g MERCK RESEARCH LABORATORIES   (United States)

^h UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Cholesterol; Coronary disease; Ezetimibe; Sitosterolemia

Indexed keywords

CAMPESTEROL; CHOLESTEROL; EZETIMIBE; PHYTOSTEROL; PLACEBO; RESIN; SITOSTEROL; STATINE DERIVATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOTHESIS; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SITOSTEROLEMIA; STORAGE DISEASE; TOOTH PAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTICHOLESTEREMIC AGENTS; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; AZETIDINES; CHILD; CHOLESTEROL; CHOLESTEROL, DIETARY; DOUBLE-BLIND METHOD; FEMALE; GENES, RECESSIVE; HUMANS; INTESTINAL ABSORPTION; LIPID METABOLISM, INBORN ERRORS; LIPOPROTEINS; MALE; MIDDLE AGED; PHYTOSTEROLS; SITOSTEROLS; TREATMENT OUTCOME;

EID: 1442335817     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000116766.31036.03     Document Type: Article

References (35)

1. Salen G, Horak I, Rothkopf M, et al. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res. 1985;26:1126-1133.
2. Kolovou G, Voudris V, Drogari E, et al. Coronary bypass grafts in a young girl with sitosterolemia. Eur Heart J. 1996;17:965-966.
3. Salen G, Shefer S, Nguyen LB, et al. Sitosterolemia. J Lipid Res. 1992; 33:945-955.
4. Björkhem I, Muri-Boberg K, Leitersdorf E. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver C, Beaudet A, Sly W, et al, eds. The Metabolic Bases of Inherited Disease. New York, NY: McGraw Hill; 2001:2961-2988.
5. Berge KE, Tian H, Graf GA, et al. Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science. 2000;290:1771-1775.
6. Lee MH, Lu K, Hazard S, et al. Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet. 2001;27:79-83.
7. Lu K, Lee M-H, Hazard S. Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet. 2001;69:278-290.
8. Klett EL, Patel S. Genetic defenses against noncholesterol sterols. Curr Opin Lipidol. 2003;14:341-345.
9. Weihrauch J, Gardner J. Sterol content of foods of plant origin. J Am Diet Assoc. 1978;73:39-47.
10. Miettinen TA, Tilvis RS, Kesaniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990; 131:20-31.
11. Salen G, Ahrens EH Jr, Grundy SM. Metabolism of beta-sitosterol in man. J Clin Invest. 1970;49:952-967.
12. Heinemann T, Axtmann G, von Bergmann K. Comparison of intestinal absorption of cholesterol with different plant sterols in man. Eur J Clin Invest. 1993;23:827-831.
13. Lütjohann D, Bjorkhem I, Beil UF, et al. Sterol absorption and sterol balance in phytosterolemia evaluated by deuterium-labeled sterols: effect of sitostanol treatment. J Lipid Res. 1995;36:1763-1773.
14. Bhattacharyya AK, Connor WE, Lin DS, et al. Sluggish sitosterol turnover and hepatic failure to excrete sitosterol into bile cause expansion of body pool of sitosterol in patients with sitosterolemia and xanthomatosis. Arterioscler Thromb. 1991;11:1287-1294.
15. Sudhop T, Sahin Y, Lindenthal B, et al. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary sterol secretion. Gut. 2002;51:860-863.
16. Mellies M, Ishikawa T, Gartside P, et al. Effects of varying maternal dietary cholesterol and phytosterol in lactating women and their infants. Am J Clin Nutr. 1978;31:1347-1354.
17. Miettinen TA, Farkkila M, Vuoristo M, et al. Serum cholestanol, cholesterol precursors, and plant sterols during placebo-controlled treatment of primary biliary cirrhosis with ursodeoxycholic acid or colchicine. Hepatology. 1995;21:1261-1268.
18. Nguyen TT, Dale LC, von Bergmann K, et al. Cholesterol-lowering effect of stanol ester in a US population of mildly hypercholesterolemic men and women: a randomized controlled trial. Mayo Clin Proc. 1999;74: 1198-1206.
19. Salen G, Shore V, Tint GS, et al. Increased sitosterol absorption, decreased removal, and expanded body pools compensate for reduced cholesterol synthesis in sitosterolemia with xanthomatosis. J Lipid Res. 1989;30:1319-1330.
20. Salen G, Tint GS, Shefer S, et al. Increased sitosterol absorption is offset by rapid elimination to prevent accumulation in heterozygotes with sitosterolemia. Arterioscler Thromb. 1992;12:563-568.
21. Miettinen T. Phytosterolaemia, xanthomatosis and premature atherosclerotic arterial disease: a case with high plant sterol absorption, impaired sterol elimination and low cholesterol synthesis. Eur J Clin Invest. 1980;10:27-35.
22. Belamarich PF, Deckelbaum RJ, Starc TJ, et al. Response to diet and cholestyramine in a patient with sitosterolemia. Pediatrics. 1990;86: 977-981.
23. Sudhop T, Lütjohann D, Kodal A, et al. Inhibition of intestinal cholesterol absorption by ezetimibe in humans. Circulation. 2002;106:1943-1948.
24. Bays HE, Moore PB, Drehobl MA, et al. Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies. Clin Ther. 2001;23:1209-1230.
25. Dujovne CA, Ettinger MP, McNeer JF, et al. Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia. Am J Cardiol. 2002;90: 1084-1091.
26. Gagne C, Bays HE, Weiss SR, et al, for the Ezetimibe Study Group. Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia. Am J Cardiol. 2002;90:1092-1097.
27. van Heek M, Farley C, Compton DS, et al. Ezetimibe selectively inhibits intestinal cholesterol absorption in rodents in the presence and absence of exocrine pancreatic function. Br J Pharmacol. 2001;134:409-417.
28. Knopp R, Bays H, Manion C. Effect of ezetimibe on serum concentrations of lipid-soluble vitamins. Atheroscler Suppl. 2001;2:90.
29. Steiner P, Freidel J, Bremmer W, et al. Standardization of micromethods for plasma cholesterol, triglyceride and HDL-cholesterol with the clinics' methodology. J Clin Chem. 1981;19:850-851.
30. Warnick G, Albers J. A comprehensive evaluation of the heparin manganese precipitation procedure for estimating high-density lipoprotein cholesterol. J Lipid Res. 1978;19:65-76.
31. Lipid Research Clinics Program. Manual of Laboratory Operations: Lipid and Lipoprotein Analysis. Washington, DC: US Department of Health, Education and Welfare; 1982. NIH Publication no. 75-628.
32. Nguyen LB, Salen G, Shefer S, et al. Unexpected failure of bile acid malabsorption to stimulate cholesterol synthesis in sitosterolemia with xanthomatosis: comparison with lovastatin. Arteriosclerosis. 1990;10: 289-297.
33. Nguyen LB, Cobb M, Shefer S, et al. Regulation of cholesterol biosynthesis in sitosterolemia: effects of lovastatin, cholestyramine, and dietary sterol restriction. J Lipid Res. 1991;32:1941-1948.
34. Patel SB, Honda A, Salen G. Sitosterolemia: exclusion of genes involved in reduced cholesterol biosynthesis. J Lipid Res. 1998;39:1055-1061.
35. Repa JJ, Dietschy JM, Turley SD. Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte. J Lipid Res. 2002;43:1864-1874.